Teladoc Health Posts Deeper Loss On Goodwill Impairment Charge Of $6.6B, Cuts FY22 Guidance

  • Teladoc Health Inc TDOC posted a Q1 EPS loss of $(41.58) compared to $(1.31) a year ago.
  • Q1 EPS loss included a non-cash goodwill impairment charge of $(41.11), stock-based compensation expense of $(0.38), and amortization of acquired intangibles of $(0.31) per share.
  • Adjusted gross margin decreased to 66.9% from 67.8% a year ago. Adjusted EBITDA decreased 4% to $54.5 million.
  • The average revenue per U.S. paid member increased to $2.52, from $2.09 in Q1 FY21 and $2.49 in Q4 FY21.
  • Revenue increased 25% to $565.4 million, missing the consensus of $568.8 million. 
  • Access fees revenue grew 29% to $491.3 million, and visit fee revenue grew 12% to $67.9 million.
  • During the quarter, the company saw overall visits jump to 4.51 million, +35% Y/Y, 
  • Paid memberships in the U.S. were 54.3 million, up 5% Y/Y.
  • Guidance: Teladoc forecasts Q2 FY22 sales of $580 million - $600 million, below the consensus of $615.26 million.
  • The company expects EPS loss of $(0.72) - $(0.60), compared to the consensus of $(0.47).
  • For FY22, Teladoc expects sales of $2.4 billion - $2.5 billion, compared to previous guidance of $2.55 billion - $2.65 billion, versus the analyst estimate of $2.58 billion.
  • It forecasts FY22 EPS loss of $(43.50) - $(43.00), compared previous outlook of $(1.60) - $(1.40).
  • Price Action: TDOC shares are down 41.1% at $33.00 during the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!